FDA's Office of Global Policy and Strategy is the focal point for all international matters concerning the Agency. Globalization fundamentally changed the environment for regulating food and medical products and has created unique regulatory challenges for FDA. The Office of Global Policy and Strategy manages FDA’s global presence with staff located at foreign posts. The overall goal of this effort is to engage more effectively abroad to be more effective at home. The Office of Global Policy and Strategy operations provide information that enables FDA officials in Product Centers, at US borders, in OC, and in the Office of Global Policy and Strategy to make better decisions about the safety, efficacy, and quality of FDA-regulated products that are destined for the USA. The Office of Global Policy and Strategy manages seven international offices which interact with counterpart regulatory authorities and multilateral organizations.
Each FDA-TRACK program area collects, analyzes, and reports its performance measures and results. Explore the progress the Office of Global Policy and Strategy is making towards it's strategic priorities below:
I. Help ensure the safety and quality of FDA-regulated products exported to the U.S. by conducting inspections in a timely fashion
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time.